Skip to content
← Full study record

NCT00792142 · MORE INFO

Limitations, agreements, and source contact

Bortezomib, Thalidomide, and Dexamethasone After Melphalan and Stem Cell Transplant in Treating Patients With Stage I-III Multiple Myeloma · Source last updated 2021-08-19

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement
pi Sponsor Employee
true
point Of Contact
email
pfrankel@coh.org
organization
City of Hope
phone
626-218-5265
title
Paul Frankel, Ph.D.
Complete source fields
certain Agreement
pi Sponsor Employee
true
point Of Contact
email
pfrankel@coh.org
organization
City of Hope
phone
626-218-5265
title
Paul Frankel, Ph.D.

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice